| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Lappe Mark is a Chief Executive Officer at Inhibrx Biosciences, Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $94.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | INBX Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 40,000 | $15.73 | $629,116.96 | +2.9% | -16.5% | +52.4% | |
| Sep 10, 2024 | INBX Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 44,000 | $15.25 | $671,150.00 | +2.3% | -1.7% | +82.1% | |
| Sep 3, 2024 | INBX Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 40,000 | $14.92 | $596,762.80 | +7.1% | -5.5% | +74.3% | |
| Aug 21, 2024 | INBX Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 40,000 | $12.96 | $518,282.20 | +70.4% | +9.5% | +85.1% |